首页> 外国专利> Liq. crystal microcapsules prodn. for narrow particle size distribution capsules - by dispersing soln. contg. thermotropic or lyotropic liq. crystal and precursor of vinyl chloride in immiscible liq. and phase sepg. for textile colouring

Liq. crystal microcapsules prodn. for narrow particle size distribution capsules - by dispersing soln. contg. thermotropic or lyotropic liq. crystal and precursor of vinyl chloride in immiscible liq. and phase sepg. for textile colouring

机译:酒晶体微胶囊产品用于窄粒径分布的胶囊-通过分散soln。续嗜热或溶致液体。不混溶液体中的氯乙烯的晶体和前体)。和相分离。用于纺织品着色

摘要

Benzofuran derivs. of formula (I) and their salts are new, R = gp. (i), R1 = H, hal, COOH,CONH2, CHO, CN, NH2 or 5-tetrazolyl; R2 = H, COOH, COOR3, CN, NO2, NH2, NHCOCF3, NHSO2CF3, or 5-tetrazolyl; R3 = H, alkyl, alkenyl or alkynyl, each contg. up to 6C; R4 = H, 1-6C alkyl, cyano-alkyl, R3OOC-alkyl, 5-tetrazolylalkyl or Ar-alkyl each alkyl gp. contg. 1-6C; A-B-C-D is CH=CHCH=N, CH=CH N=CH N=CHCH=CH, CH=CH CONR4; CH=CHNR4CO, CONR4CH=CH or NR4 COCH=CH, in which the H atoms of the CH gps. are substd. with 1-6C alkyl, halogen, COOR3, CN and/or S-tetrazolyl; Ar = Ph opt. mono- or di-substd. with halogen, R3, CF3, COOR3, CN, OR3, NO2, NH2, NHCOCF3, NHSO2 CF3 or 5-tetrazolyl. USE/ADVANTAGE - (I) have angiotensin II antagonistic properties and can be used to treat angiotensin II dependent hypertension, aldosteronism and cardiac insufficiency and disorders of the CNS. In partic. (I) can be used for the prophylaxis and therapy of hypertonia, cardiac insufficiency, hyperaldosteronism, hypertrophy and hyperplasia of blood vessels and the heart, angina pectoris, cardiac infarction, strokes resteosis after angioplasty or by-pass operation, arteriosclerosis, increased inner eye pressure, glaucoma, muscular degeneration, hyperuricaemia, kidney function disorders e.g. kidney failure, nephropathiadiabetic, retinopathia diabetica, psoriasis, angiotensin II mediated disorders in female fertility organs, cognitive disorders, e.g. dementia, amnesia, memory disorders, anxiety conditions, depressions, and/or epilepsy. Suitable daily doses are 0.1-50 (esp. 1-100) mg/kg.
机译:苯并呋喃衍生。式(I)的化合物及其盐是新的,R = gp。 (i)R 1 = H,hal,COOH,CONH 2,CHO,CN,NH 2或5-四唑基; R 2 = H,COOH,COOR 3,CN,NO 2,NH 2,NHCOCF 3,NHSO 2 CF 3或5-四唑基; R 3 = H,分别为烷基,烯基或炔基。最高6C; R 4 = H,烷基gp为H,1-6C烷基,氰基烷基,R 3 OOC烷基,5-四唑基烷基或Ar-烷基。续1-6C; A-B-C-D为CH = CHCH = N,CH = CH N = CH N = CHCH = CH,CH = CH CONR4; CH = CHNR4CO,CONR4CH = CH或NR4 COCH = CH,其中CH的H原子为gps。被取代。具有1-6C烷基,卤素,COOR3,CN和/或S-四唑基; Ar = Ph opt。单或双取代。含卤素,R3,CF3,COOR3,CN,OR3,NO2,NH2,NHCOCF3,NHSO2 CF3或5-四唑基。用途/优点-(I)具有血管紧张素II拮抗特性,可用于治疗血管紧张素II依赖性高血压,醛固酮增多症和心脏供血不足以及中枢神经系统疾病。特别是。 (I)可用于预防和治疗高渗,心脏功能不全,醛固酮增多症,血管和心脏的肥大和增生,心绞痛,心梗,血管成形术或旁路手术后的中风再狭窄,动脉硬化,内眼增高压力,青光眼,肌肉变性,高尿酸血症,肾功能异常肾功能衰竭,肾病性糖尿病,糖尿病性视网膜病,银屑病,女性生育器官中血管紧张素II介导的疾病,认知障碍例如痴呆,健忘症,记忆障碍,焦虑症,抑郁症和/或癫痫病。合适的日剂量为0.1-50(尤其是1-100)mg / kg。

著录项

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号